TLR4 and hepatocellular carcinoma: Also, an increased fecal abundance of Gram-negative E. coli has been found in the stool of cirrhotic patients with HCC, and this may lead to enhanced intestinal and hepatic inflammation mediated by the LPS-TLR4-NF-kB pathway.